These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8500885)

  • 1. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
    Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
    Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
    Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
    J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active and passive immunization against Plasmodium yoelii sporozoites.
    Charoenvit Y; Sedegah M; Yuan LF; Gross M; Cole C; Bechara R; Leef MF; Robey FA; Lowell GH; Beaudoin RL
    Bull World Health Organ; 1990; 68 Suppl(Suppl):26-32. PubMed ID: 1709834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
    Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
    Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
    Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
    Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii.
    White WI; Evans CB; Taylor DW
    Infect Immun; 1991 Oct; 59(10):3547-54. PubMed ID: 1894361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.
    Eslava I; Payares G; Pernia BM; Holder AA; Spencer LM
    Malar J; 2010 Feb; 9():46. PubMed ID: 20146804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine.
    Silva-Flannery LM; Cabrera-Mora M; Jiang J; Moreno A
    Microbes Infect; 2009 Jan; 11(1):83-91. PubMed ID: 19015042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
    Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
    Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.
    Mauduit M; Grüner AC; Tewari R; Depinay N; Kayibanda M; Chavatte JM; Franetich JF; Crisanti A; Mazier D; Snounou G; Rénia L
    PLoS One; 2009 Nov; 4(11):e7717. PubMed ID: 19890387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum.
    Del Giudice G; Tougne C; Renia L; Ponnudurai T; Corradin G; Pessi A; Verdini AS; Louis JA; Mazier D; Lambert PH
    Mol Immunol; 1991 Sep; 28(9):1003-9. PubMed ID: 1922106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
    Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
    Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
    Vukovic P; Hogarth PM; Barnes N; Kaslow DC; Good MF
    Infect Immun; 2000 May; 68(5):3019-22. PubMed ID: 10769007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
    Sedegah M; Hedstrom R; Hobart P; Hoffman SL
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9866-70. PubMed ID: 7937907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites.
    Mellouk S; Berbiguier N; Druilhe P; Sedegah M; Galey B; Yuan L; Leef M; Charoenvit Y; Paul C; Hoffman S
    Bull World Health Organ; 1990; 68 Suppl(Suppl):52-9. PubMed ID: 2094592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.
    Keitany GJ; Sack B; Smithers H; Chen L; Jang IK; Sebastian L; Gupta M; Sather DN; Vignali M; Vaughan AM; Kappe SH; Wang R
    Infect Immun; 2014 Dec; 82(12):5143-53. PubMed ID: 25267837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
    Narum DL; Ogun SA; Batchelor AH; Holder AA
    Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.